Found: 136
Select item for more details and to access through your institution.
200 years after Darwin.
- Published in:
- 2009
- By:
- Publication type:
- journal article
The major histocompatibility complex and antibody-mediated limbic encephalitis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Evaluation of HMG-CoA reductase inhibitors for multiple sclerosis: opportunities and obstacles.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Immunomodulatory synergy by combination of atorvastatin and glatiramer acetate in treatment of CNS autoimmunity.
- Published in:
- 2006
- By:
- Publication type:
- journal article
The role of the complement system in Multiple Sclerosis: A review.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.970486
- By:
- Publication type:
- Article
T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy.
- Published in:
- Multiple Sclerosis Journal, 2023, v. 29, n. 6, p. 648, doi. 10.1177/13524585221134216
- By:
- Publication type:
- Article
Persistent severe lymphopenia 5 years after dimethyl fumarate discontinuation.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 8, p. 1306, doi. 10.1177/1352458520988149
- By:
- Publication type:
- Article
Adverse event profile differences between rituximab and ocrelizumab: Findings from the FDA Adverse Event Reporting Database.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 7, p. 1066, doi. 10.1177/1352458520949986
- By:
- Publication type:
- Article
The temporal and causal relationship between inflammation and neurodegeneration in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2020, v. 26, n. 8, p. 876, doi. 10.1177/1352458519886943
- By:
- Publication type:
- Article
Presenilin1 regulates Th1 and Th17 effector responses but is not required for experimental autoimmune encephalomyelitis.
- Published in:
- PLoS ONE, 2018, v. 13, n. 8, p. 1, doi. 10.1371/journal.pone.0200752
- By:
- Publication type:
- Article
(DXT40) Effect of the S1P1/5 Receptor Modulator Ozanimod on Cognitive Processing Speed in Subjects with Relapsing Multiple Sclerosis: Design of the ENLIGHTEN Study.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 29
- By:
- Publication type:
- Article
The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis.
- Published in:
- Journal of Neuroinflammation, 2013, v. 10, n. 1, p. 1, doi. 10.1186/1742-2094-10-67
- By:
- Publication type:
- Article
The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Lymph node-derived donor encephalitogenic CD4+ T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Spinal gout: A rare cause of paraplegia.
- Published in:
- Neurology India, 2015, v. 63, n. 2, p. 284, doi. 10.4103/0028-3886.156318
- By:
- Publication type:
- Article
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease.
- Published in:
- Nature, 2002, v. 420, n. 6911, p. 78, doi. 10.1038/nature01158
- By:
- Publication type:
- Article
Simplification of combination antiretroviral therapy (cART) and the brain—a real-life experience.
- Published in:
- Journal of NeuroVirology, 2019, v. 25, n. 2, p. 174, doi. 10.1007/s13365-018-0701-x
- By:
- Publication type:
- Article
A systematic review of the incidence and prevalence of comorbidity in multiple sclerosis: Overview.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 3, p. 263, doi. 10.1177/1352458514564491
- By:
- Publication type:
- Article
A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 3, p. 282, doi. 10.1177/1352458514564490
- By:
- Publication type:
- Article
A systematic review of the incidence and prevalence of cancer in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 3, p. 294, doi. 10.1177/1352458514564489
- By:
- Publication type:
- Article
The incidence and prevalence of comorbid gastrointestinal, musculoskeletal, ocular, pulmonary, and renal disorders in multiple sclerosis: A systematic review.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 3, p. 332, doi. 10.1177/1352458514564488
- By:
- Publication type:
- Article
A systematic review of the incidence and prevalence of sleep disorders and seizure disorders in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 3, p. 342, doi. 10.1177/1352458514564486
- By:
- Publication type:
- Article
A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 3, p. 318, doi. 10.1177/1352458514564485
- By:
- Publication type:
- Article
The incidence and prevalence of psychiatric disorders in multiple sclerosis: A systematic review.
- Published in:
- Multiple Sclerosis Journal, 2015, v. 21, n. 3, p. 305, doi. 10.1177/1352458514564487
- By:
- Publication type:
- Article
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence?
- Published in:
- Multiple Sclerosis Journal, 2014, v. 20, n. 10, p. 1304, doi. 10.1177/1352458514531843
- By:
- Publication type:
- Article
A genetic variant of the anti-apoptotic protein Akt predicts natalizumab-induced lymphocytosis and post-natalizumab multiple sclerosis reactivation.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 1, p. 59, doi. 10.1177/1352458512448106
- By:
- Publication type:
- Article
Time to talk about timing – when to start, stop and change anti-migratory drugs in MS.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 7, p. 1022, doi. 10.1177/1352458511432896
- By:
- Publication type:
- Article
Reelin depletion protects against autoimmune encephalomyelitis by decreasing vascular adhesion of leukocytes.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 556, p. 1, doi. 10.1126/scitranslmed.aay7675
- By:
- Publication type:
- Article
DNA beta-amyloid(1-42) trimer immunization for Alzheimer disease in a wild-type mouse model.
- Published in:
- 2009
- By:
- Publication type:
- journal article
DNA β-Amyloid1-42 Trimer Immunization for Alzheimer Disease in a Wild-Type Mouse Model.
- Published in:
- JAMA: Journal of the American Medical Association, 2009, v. 302, n. 16, p. 1796, doi. 10.1001/jama.2009.1547
- By:
- Publication type:
- Article
Clinical trials in multiple sclerosis: past, present, and future.
- Published in:
- Polish Journal of Neurology & Neurosurgery / Neurologia i Neurochirurgia Polska, 2022, v. 56, n. 3, p. 228, doi. 10.5603/PJNNS.a2022.0041
- By:
- Publication type:
- Article
Statins as potential therapeutic agents in multiple sclerosis.
- Published in:
- Current Neurology & Neuroscience Reports, 2004, v. 4, n. 3, p. 237, doi. 10.1007/s11910-004-0044-2
- By:
- Publication type:
- Article
Dimethyl Fumarate Delays Multiple Sclerosis in Radiologically Isolated Syndrome.
- Published in:
- Annals of Neurology, 2023, v. 93, n. 3, p. 604, doi. 10.1002/ana.26555
- By:
- Publication type:
- Article
Genome sequencing uncovers phenocopies in primary progressive multiple sclerosis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
CD19 as a molecular target in CNS autoimmunity.
- Published in:
- Acta Neuropathologica, 2014, v. 128, n. 2, p. 177, doi. 10.1007/s00401-014-1313-z
- By:
- Publication type:
- Article
Opinion: Statins-a cure-all for the brain?
- Published in:
- Nature Reviews Neuroscience, 2005, v. 6, n. 4, p. 325, doi. 10.1038/nrn1652
- By:
- Publication type:
- Article
TLR3 agonism re‐establishes CNS immune competence during α4‐integrin deficiency.
- Published in:
- Annals of Clinical & Translational Neurology, 2018, v. 5, n. 12, p. 1543, doi. 10.1002/acn3.664
- By:
- Publication type:
- Article
Disease-Modifying Agents for Multiple Sclerosis: Recent Advances and Future Prospects.
- Published in:
- Drugs, 2008, v. 68, n. 17, p. 2445, doi. 10.2165/0003495-200868170-00004
- By:
- Publication type:
- Article
Pharmacological Treatment of Early Multiple Sclerosis.
- Published in:
- Drugs, 2008, v. 68, n. 1, p. 73, doi. 10.2165/00003495-200868010-00005
- By:
- Publication type:
- Article
Ectopic Lymphoid Follicles in Multiple Sclerosis: Centers for Disease Control?
- Published in:
- Frontiers in Neurology, 2020, v. 11, p. N.PAG, doi. 10.3389/fneur.2020.607766
- By:
- Publication type:
- Article
The Combination of Interferon-Beta and HMG-CoA Reductase Inhibition in Multiple Sclerosis: Enthusiasm Lost too Soon? J. Sellner et al. Combination of IFN-β and Statins in MS.
- Published in:
- CNS Neuroscience & Therapeutics, 2010, v. 16, n. 6, p. 362, doi. 10.1111/j.1755-5949.2010.00179.x
- By:
- Publication type:
- Article
The sequential natalizumab – alemtuzumab therapy in patients with relapsing forms of multiple sclerosis (SUPPRESS) trial – Part I: Rationale and objectives.
- Published in:
- Journal of Central Nervous System Disease, 2022, p. 1, doi. 10.1177/11795735221123911
- By:
- Publication type:
- Article
Utilization of a neurology specialty service by primary care providers for headache management at a tertiary care hospital.
- Published in:
- Journal of Central Nervous System Disease, 2022, p. 1, doi. 10.1177/11795735221113102
- By:
- Publication type:
- Article
Lymphomatoid papulosis in a patient treated with glatiramer acetate and the glatiramoid Glatopa for multiple sclerosis: A case report.
- Published in:
- Journal of Central Nervous System Disease, 2021, p. 1, doi. 10.1177/11795735211053784
- By:
- Publication type:
- Article
Intractable and highly active relapsing multiple sclerosis - role of alemtuzumab.
- Published in:
- Neuropsychiatric Disease & Treatment, 2015, v. 11, p. 2405, doi. 10.2147/NDT.S90473
- By:
- Publication type:
- Article
DNA Immunization Against Amyloid beta 42 has High Potential as Safe Therapy for Alzheimer's Disease as it Diminishes Antigen-Specific Th1 and Th17 Cell Proliferation.
- Published in:
- Cellular & Molecular Neurobiology, 2011, v. 31, n. 6, p. 867, doi. 10.1007/s10571-011-9680-7
- By:
- Publication type:
- Article
A regulatory immune response after DNA vaccination against Aß42
- Published in:
- 2012
- By:
- Publication type:
- Abstract
T cell responses after DNA Abeta-42 trimer immunization in mice indicate the potential for safe immunotherapy for Alzheimer's disease
- Published in:
- 2011
- By:
- Publication type:
- Abstract
Abeta42 trimer DNA vaccination is effective and safe as potential therapy for early Alzheimer's disease
- Published in:
- 2009
- By:
- Publication type:
- Abstract